United Therapeutics Corporation (UTHR)
- Exchange
- NASDAQ
- Symbol
- UTHR
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
- Country
- USA
Stock price
At close: November 22, 2024
-
Open367.94
-
High374.02
-
Low367.90
-
Close372.89
-
Volume254,183
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
6.56
Receivables turnover
8.13
Payables turnover
130.91
Working capital turnover
0.83
Days of inventory on hand (DOH)
55.66
Days of sales outstanding (DSO)
44.88
Number of days of payables
2.79
Fixed asset turnover
2.17
Total asset turnover
0.32
Current ratio
4.41
Quick ratio
4.09
Cash ratio
3.74
Cash conversion cycle
97.76
Debt-to-assets ratio
0.04
Debt-to-capital ratio
0.05
Debt-to-equity ratio
0.05
Financial leverage ratio
1.20
Interest coverage
22.49
Gross profit margin
91.26%
Operating profit margin
52.24%
Pretax margin
56.18%
Net profit margin
43.42%
Operating return on assets (Operating ROA)
16.53%
Return on assets (ROA)
13.74%
Return on total capital
21.22%
Return on equity (ROE)
16.46%